Correlation Between Revelation Biosciences and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Revelation Biosciences and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Biohaven Pharmaceutical.
Diversification Opportunities for Revelation Biosciences and Biohaven Pharmaceutical
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Revelation and Biohaven is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Biohaven Pharmaceutical
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Biohaven Pharmaceutical. In addition to that, Revelation Biosciences is 2.18 times more volatile than Biohaven Pharmaceutical Holding. It trades about -0.06 of its total potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about 0.06 per unit of volatility. If you would invest 2,313 in Biohaven Pharmaceutical Holding on August 31, 2024 and sell it today you would earn a total of 2,288 from holding Biohaven Pharmaceutical Holding or generate 98.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.73% |
| Values | Daily Returns |
Revelation Biosciences vs. Biohaven Pharmaceutical Holdin
Performance |
| Timeline |
| Revelation Biosciences |
| Biohaven Pharmaceutical |
Revelation Biosciences and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and Biohaven Pharmaceutical
The main advantage of trading using opposite Revelation Biosciences and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.| Revelation Biosciences vs. Cue Biopharma | Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. Inhibrx | Revelation Biosciences vs. Molecular Partners AG |
| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |